Divided success in PM(NOC) actions regarding glatiramer acetate
Pharma in Brief
JANUARY 17, 2021
The Court found that the prior art documents cited by Pharmascience ( Pinchasi 2007 and Karussis 2006 ) neither disclosed nor enabled the asserted claims of the 437 Patent. The Court found that the statements in Karussis 2006 were “based on hypothesis and speculation, and not evidence-based.”. The Court held: No disclosure.
Let's personalize your content